NEW YORK (The Deal) -- Four law firms with prominent antitrust practices sided with Monsanto (MON) contention that its proposed acquisition of Syngenta (SYT) would face little antitrust risk in an analysis of the merger circulated Thursday.
Lawyers from Arnold & Porter; Cadwalader, Wickersham & Taft; Paul Hastings and Wilmer Cutler Pickering Hale and Door disputed Syngenta's claim that Monsanto's proposed antitrust remedies are inadequate and that the deal's integration of Monsanto's seed business with Syngenta's crop protection chemicals business would pose vertical competition issues likely to create significant worries among antitrust regulators.
"Nobody with more than a passing knowledge of global antitrust enforcement trends and the structure of this industry would ever claim that a transaction is likely to be blocked on conglomerate grounds, and certainly not that this transaction would be," the attorneys wrote.
The law firms responsible for Thursday's report all have done work for Monsanto in recent years, either in antitrust, litigation or intellectual property proceedings. Lawyers in those firm's antitrust practices include Cadwalader partner Rick Rule -- who represented another seed company, Delta and Pine Land Co., in its 2007 acquisition by Monsanto -- and Paul, Hastings partner MJ Moltenbray, who represented Monsanto in the same deal.
Syngenta's media relations representatives did not respond to a request for comment on the lawyers' white paper.
Earlier this week Syngenta Chairman Michel Demaré reiterated his board's refusal to consider the unsolicited $44.3 billion buyout offer from Monsanto and distributed a video explaining the reason for not engaging in talks with the rival seed and agricultural chemicals business. He argued that Monsanto's offer undervalues Switzerland-based Syngenta and ignores the likelihood that antitrust officials will seek to block the deal despite Monsanto's upfront offer to divest Syngenta's seed and traits business and pay Syngenta a $2 billion breakup fee if the deal fails to win antitrust approval.